Various Immunotherapy Combinations Continue to Be Explored in NSCLC – OncLive
OncLive |
Various Immunotherapy Combinations Continue to Be Explored in NSCLC
OncLive “We are still searching for the right combinations including immunotherapy for NSCLC,” said Daniel E. Haggstrom, MD. “We have proven efficacy as single agents and in combination with chemotherapy; however, as newer agents are improved, the landscape … |
